Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical Study
Clinical trial NCT03225287 · TERMINATED
Trial details
- NCT number
- NCT03225287
- Sponsor
- Ra Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2021-09-07
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.